Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination-Reference-Cited by-同舟云学术

Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination

Published:2024-08 Issue:5 Volume:54 Page:104886
ISSN:2666-9919
Container-title:Infectious Diseases Now
language:en
Short-container-title:Infectious Diseases Now

Author:

Durier Christine^ORCID,Ninove Laetitia,van der Werf Sylvie,Lefebvre Maeva,Desaint Corinne,Bauer Rebecca^ORCID,Attia Mikael,Lecompte Anne-Sophie,Lachatre Marie,Maakaroun-Vermesse Zoha,Nicolas Jean-François,Verdon Renaud,Kiladjian Jean-Jacques,Loubet Paul,Schmidt-Mutter Catherine^ORCID,Corbin Violaine,Ansart Séverine,Melica Giovanna,Resch Martine,Netzer Emmanuelle,Kherabi Yousra^ORCID,Tardieu Raphaëlle,Lelièvre Jean-Daniel,Tartour Eric,Meyer Laurence,de Lamballerie Xavier,Launay Odile

Funder

ANRS

Publisher

Elsevier BV

Reference32 articles.

1. Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines;Botton;Vaccine,2022

2. Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study;Bouillon;BMJ Med,2022

3. Effectiveness of messenger RNA coronavirus disease 2019 (COVID-19) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a cohort of Healthcare personnel;Swift;Clin Infect Dis,2021

4. Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines;Bowen;Science,2022

5. A systematic review and meta-analysis on the real-world effectiveness of COVID-19 vaccines against infection, symptomatic and severe COVID-19 disease caused by the omicron Variant (B.1.1.529);Mohammed;Vaccines,2023